Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Muvon Plus is a multi-ingredient dietary supplement designed to support joint health and manage symptoms associated with osteoarthritis, particularly of the knee. Its formulation combines hydrolyzed collagen, chondroitin sulfate, and vitamin C (ascorbic acid). Hydrolyzed collagen provides essential peptides and amino acids required for the maintenance and repair of the cartilaginous matrix. Chondroitin sulfate, a major component of the extracellular matrix in cartilage, contributes to joint elasticity and resistance to compression. Vitamin C serves as a critical biochemical cofactor for the enzymatic hydroxylation of proline and lysine residues, a necessary step in endogenous collagen synthesis, while also providing antioxidant protection to joint tissues. Clinical research has evaluated its impact on the biomechanical behavior of the knee joint, suggesting improvements in functional outcomes for patients with grade II osteoarthritis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Muvon Plus.